IPO registrations (S-1, F-1) · Registrants
PHARMION CORP
- SEC CIK
- 1203866 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2003-08-21, last 2004-06-21; 2 initial registrations, 4 amendments
- Outcome
- Final prospectus filed 2003-11-06
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Business address
- 2525 28TH STREET, Boulder, CO 80301
- EDGAR entity type
- operating
- Insiders and CEO pay
- PHARMION CORP on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2003-10-30)
- Final price
- $14.00 per share, within the range (424B4 filed 2003-11-06, an initial public offering)
- Shares sold
- 6,000,000
- Gross proceeds
- $84,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol PHRM
- Lead underwriters
- Inventories — (1,608,674 shares)
- Syndicate
- June 30, June 30 (2,001)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Federal award recipient: PHARMION CORPORATION Fuzzy (name and state)
- SEC filer: PHARMION CORP EXACT (CIK (EXACT))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2003-08-21 | S-1 | S-1 (registration) | PHARMION CORP | 0001035704-03-000642 ↗ |
| 2003-09-26 | S-1/A | S-1/A (amendment) | PHARMION CORP | 0000950134-03-013044 ↗ |
| 2003-10-17 | S-1/A | S-1/A (amendment) | PHARMION CORP | 0000950123-03-011465 ↗ |
| 2003-10-30 | S-1/A | S-1/A (amendment) | PHARMION CORP | 0000950123-03-011941 ↗ |
| 2003-11-06 | 424B4 | 424B4 (final prospectus) | PHARMION CORP | 0000950123-03-012242 ↗ |
| 2004-06-08 | S-1 | S-1 (registration) | PHARMION CORP | 0001035704-04-000301 ↗ |
| 2004-06-21 | S-1/A | S-1/A (amendment) | PHARMION CORP | 0001035704-04-000319 ↗ |
| 2004-07-01 | S-1MEF | S-1MEF (added securities) | PHARMION CORP | 0000950123-04-008097 ↗ |
| 2004-07-01 | 424B4 | 424B4 (final prospectus) | PHARMION CORP | 0000950123-04-008117 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2003-10-30 | S-1/A | registration statement | $14.00–$16.00 | $15.00 | 6,000,000 | $90,000,000 | Nasdaq PHRM | 5 | primary document; range, price sentence, shares headline, proceeds computed, underwriting table 2 | document ↗ |
| 2003-11-06 | 424B4 | final prospectus | $14.00 | 6,000,000 | $84,000,000 | Nasdaq PHRM | 2 | primary document; price sentence, shares headline, proceeds computed, underwriting table 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Dupont Steven N | Officer | EVP and General Counsel; EVP, General Counsel; Executive VP, General Counsel; VP and General Counsel; VP, General Counsel | 7 | 2006–2008 | |
| MAST ERLE T | Officer | EVP, CFO; Executive VP and CFO | 7 | 2006–2008 | |
| MAHAFFY PATRICK J | Director,Officer; Officer | CEO, President; President and CEO | 6 | 2006–2008 | |
| HEMBERGER JUDITH A | Director,Officer | Exec VP and COO | 1 | 2006 | |
| McKinley Edward J | Director | 6 | 2006–2008 | ||
| IVERS-READ GILLIAN C | Officer | EVP, Development Operations; Executive Vice President | 7 | 2006–2008 | |
| BLAIR JAMES C | Director | 9 | 2006–2008 | ||
| ATWOOD BRIAN G | Director | 3 | 2006–2008 | ||
| BARRETT M JAMES | Director | 7 | 2006–2008 | ||
| GARNER CAM L | Director | 3 | 2006–2008 | ||
| REED JOHN C | Director | 3 | 2006–2008 | ||
| SPICKSCHEN THORLEF | Director | 3 | 2006–2008 | ||
| Allen Andrew R | Officer | Chief Medical Officer & E.V.P.; Chief Medical Officer, EVP; Chief Medical Officer, Exec VP | 8 | 2006–2008 | |
| COSGRAVE MICHAEL | Officer | EVP, Chief Commercial Officer; EVP, Global Commercial | 5 | 2006–2008 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | PHARMION CORPORATION | CO | Form 5500 (employee benefit plans) | name and state |
| Federal award recipient | PHARMION CORPORATION | CO | Federal spending (USAspending) | name and state |
| SEC filer | PHARMION CORP | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Pharmion Corporation | CO | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, CO first:
- ALLOS THERAPEUTICS INC CO
- ARRAY BIOPHARMA INC CO
- MYOGEN INC CO
- GLOBEIMMUNE INC CO
- Statera Biopharma, Inc. CO
- AYTU BIOPHARMA, INC CO
- Ampio Pharmaceuticals, Inc. CO
- MusclePharm Corp CO
- United Cannabis Corp CO
- Clovis Oncology, Inc. CO
In other datasets, the same topic (Health) in CO:
- Nonprofit: 3 4 FIGHTING PARKINSONS (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health